Table 1.
Characteristic | AML | B‐ALL |
---|---|---|
Patient number | n = 15 | n = 12 |
Age at diagnosis (years, median, range) | 10.66 (4.03–17.36) | 11.64 (2.31–17.13) |
Relapse, No. (%) | 4 (27%) | 1 (8%) |
In CR1 | 11 (73%) | 11 (92%) |
In CR2 | 4 (27%) | 1 (8%) |
Procedure type | ||
Diagnostic | 15 (100%) |
12 (100%) |
CMV results | ||
CMV negative | 7 (47%) | 9 (75%) |
IgG reactive | 6 (40%) | 0 (0%) |
IgM non‐reactive | 2 (13%) | 1 (8%) |
Unavailable | 0 (0%) | 2 (17%) |
AML, acute myeloid leukaemia; B‐ALL, B‐cell acute lymphoblastic leukaemia; CMV, cytomegalovirus; CR, complete remission.